Tunitas Therapeutics Garners $10,000,000 Series A Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8fb52495-d228-434a-b94c-75dabd9bfff5 - Date
10/1/2015 - Company Name
Tunitas Therapeutics - Mailing Address
409 Illinois Street San Francisco, CA 94158 USA - Company Description
Tunitas Therapeutics is a biopharmaceutical company that is developing novel and precisely targeted protein therapeutics with the potential to dramatically change the lives of allergy sufferers. - Website
http://www.tunitastherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$10,000,000 - Transaction Round
Series A - Proceeds Purposes
The funding will also be used to continue the development of Tunitas’ pipeline of novel targeted vaccines for the treatment of specific allergies. - M&A Terms
- Venture Investor
Ally Bridge Group - Venture Investor
WuXi PharmaTech
